repaglinide has been researched along with Alloxan Diabetes in 27 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (11.11) | 18.2507 |
| 2000's | 7 (25.93) | 29.6817 |
| 2010's | 14 (51.85) | 24.3611 |
| 2020's | 3 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Aziz, YMA; Elewa, M; Elshihawy, HA; Said, MM; Salem, MG | 1 |
| Abdollahi, M; Asgarian, S; Baeeri, M; Dehpour, AR; Emamgholipour, Z; Firoozpour, L; Foroumadi, A; Foroumadi, R; Gholami, M; Goli, F; Keykhaei, M | 1 |
| Bayram, C; Cetin, M; Hacimuftuoglu, A; Kaplan, ABU; Taghizadehghalehjoughi, A; Yildirim, S | 1 |
| Jain, AK; Jain, SK; Mishra, K; Sahu, P | 1 |
| Minaiyan, M; Pendar, Y; Tabbakhian, M; Tavakoli, N | 1 |
| Awad, GA; El-Shamy, Ael-H; Elmowafy, E; Osman, R | 1 |
| Awad, GA; El-Shamy, AH; Elmowafy, E; Osman, R | 1 |
| Li, F; Ling, Z; Liu, C; Liu, L; Liu, X; Shu, N; Xu, D; Zhang, M; Zhong, Z | 1 |
| Chinwuba Okoye, T; Chukwunonso Obi, B; Nonye Igwe, C; Okpashi, VE; Olisah Alumanah, E | 1 |
| Ahmadi, M; Ghassami, E; Minayian, M; Varshosaz, J | 1 |
| Goud, T; Maddi, S; Nayakanti, D; Thatipamula, RP | 1 |
| Akhtar, J; Aqil, M; Fareed, S; Khalid, M; Siddiqui, HH | 1 |
| Gumieniczek, A; Krzywdzińska, M; Nowak, M | 1 |
| Jain, S; Saraf, S | 1 |
| Jain, A; Rawat, MK; Singh, S | 2 |
| Date, AA; Jagtap, A; Nagarsenker, MS; Vador, N | 1 |
| Reddy, PJ; Sekhar, MC | 1 |
| Gumieniczek, A; Owczarek, B; Pawlikowska, B | 1 |
| Abdel-Salam, OM; Arbid, MS; el-Batran, SA; el-Shenawy, SM; Nofal, SM | 1 |
| Gumieniczek, A | 3 |
| Bojarska-Junak, A; Gumieniczek, A; Hopkała, H; Roliński, J | 1 |
| Fuhlendorff, J; Ladrière, L; Malaisse, WJ; Malaisse-Lagae, F | 1 |
| Ladrière, L; Laghmich, A; Malaisse, WJ; Malaisse-Lagae, F | 1 |
| Balfour, JA; Faulds, D | 1 |
1 review(s) available for repaglinide and Alloxan Diabetes
| Article | Year |
|---|---|
Repaglinide.
Topics: Animals; Carbamates; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Glyburide; Humans; Hypoglycemic Agents; Islets of Langerhans; Piperidines; Randomized Controlled Trials as Topic; Stereoisomerism | 1998 |
26 other study(ies) available for repaglinide and Alloxan Diabetes
| Article | Year |
|---|---|
Synthesis and molecular modeling of novel non-sulfonylureas as hypoglycemic agents and selective ALR2 inhibitors.
Topics: Aldehyde Reductase; Animals; Diabetes Complications; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Enzyme Inhibitors; Hypoglycemic Agents; Mice; Mice, Inbred BALB C; Models, Molecular; Molecular Structure; Structure-Activity Relationship; Sulfonylurea Compounds | 2019 |
Antidiabetic and neuroprotective effects of a novel repaglinide analog.
Topics: Adenosine Triphosphate; Animals; Antioxidants; Benzoic Acid; Biomarkers; Blood Glucose; Carbamates; Diabetes Mellitus, Experimental; Eosine Yellowish-(YS); Glucokinase; Glucose Transport Proteins, Facilitative; Glutamate Dehydrogenase; Hematoxylin; Hypoglycemic Agents; Insulin; KATP Channels; Molecular Docking Simulation; Neuroprotective Agents; Oxidative Stress; Piperidines; Potassium; Rats; Reactive Oxygen Species; RNA, Messenger; Secretagogues | 2022 |
In Vivo Evaluation of Nanoemulsion Formulations for Metformin and Repaglinide Alone and Combination.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Hypoglycemic Agents; Metformin; Rats | 2023 |
Repaglinide and Metformin-Loaded Amberlite Resin-Based Floating Microspheres for the Effective Management of Type 2 Diabetes.
Topics: Animals; Carbamates; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Metformin; Mice; Microspheres; Piperidines; Rats; Resins, Synthetic | 2021 |
Preparation and evaluation of a controlled drug release of repaglinide through matrix pellets: in vitro and in vivo studies.
Topics: Administration, Oral; Animals; Blood Glucose; Carbamates; Cellulose; Diabetes Mellitus, Experimental; Drug Evaluation, Preclinical; Drug Implants; Hypoglycemic Agents; Lactose; Male; Piperidines; Rats; Rats, Wistar | 2014 |
Nasal polysaccharides-glucose regulator microparticles: optimization, tolerability and antidiabetic activity in rats.
Topics: Administration, Intranasal; Animals; Blood Glucose; Carbamates; Diabetes Mellitus, Experimental; Drug Delivery Systems; Hypoglycemic Agents; Male; Nasal Mucosa; Piperidines; Rats | 2014 |
Nanocomplexes of an insulinotropic drug: optimization, microparticle formation, and antidiabetic activity in rats.
Topics: Administration, Intranasal; Animals; Blood Glucose; Carbamates; Cell Line; Cell Survival; Chemistry, Pharmaceutical; Diabetes Mellitus, Experimental; Drug Carriers; Hypoglycemic Agents; Male; Microspheres; Nasal Mucosa; Piperidines; Rats, Wistar | 2014 |
Co-administration of paroxetine increased the systemic exposure of pravastatin in diabetic rats due to the decrease in liver distribution.
Topics: Administration, Intravenous; Administration, Oral; Animals; Body Fluids; Carbamates; Cell Separation; Diabetes Mellitus, Experimental; Diet, High-Fat; Disease Models, Animal; Feces; Hepatocytes; Intestinal Absorption; Liver; Male; Paroxetine; Piperidines; Pravastatin; Rats, Sprague-Dawley; Tissue Distribution | 2015 |
Comparative Study of the Antioxidant Effects of Metformin, Glibenclamide, and Repaglinide in Alloxan-Induced Diabetic Rats.
Topics: Alloxan; Animals; Antioxidants; Biomarkers; Blood Glucose; Carbamates; Catalase; Diabetes Complications; Diabetes Mellitus, Experimental; Glutathione; Glyburide; Hypoglycemic Agents; Lipid Peroxidation; Male; Malondialdehyde; Metformin; Oxidative Stress; Piperidines; Rats; Superoxide Dismutase | 2016 |
Enhancement of solubility and antidiabetic effects of Repaglinide using spray drying technique in STZ-induced diabetic rats.
Topics: Animals; Calorimetry, Differential Scanning; Carbamates; Diabetes Mellitus, Experimental; Hypoglycemic Agents; Piperidines; Rats; Solubility; Spectroscopy, Fourier Transform Infrared | 2017 |
Altered pharmacokinetics and pharmacodynamics of repaglinide by ritonavir in rats with healthy, diabetic and impaired hepatic function.
Topics: Alloxan; Animals; Blood Glucose; Carbamates; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Diabetes Mellitus, Experimental; Drug Synergism; Male; Piperidines; Rats; Ritonavir | 2016 |
Nanoemulsion: for improved oral delivery of repaglinide.
Topics: Administration, Oral; Animals; Biopharmaceutics; Carbamates; Diabetes Mellitus, Experimental; Drug Stability; Emulsions; Hypoglycemic Agents; Lipids; Nanoparticles; Piperidines; Polysorbates; Rats; Solubility | 2016 |
Modulation of nitrosative/oxidative stress in the lung of hyperglycemic rabbits by two antidiabetics, pioglitazone and repaglinide.
Topics: Administration, Oral; Animals; Blood Glucose; Carbamates; Catalase; Diabetes Mellitus, Experimental; Glutathione; Glutathione Peroxidase; Hyperglycemia; Hypoglycemic Agents; Lipid Peroxidation; Lung; Male; Oxidative Stress; Pioglitazone; Piperidines; Rabbits; Reactive Nitrogen Species; Superoxide Dismutase; Thiazolidinediones; Tyrosine | 2009 |
Repaglinide-loaded long-circulating biodegradable nanoparticles: rational approach for the management of type 2 diabetes mellitus.
Topics: Administration, Oral; Animals; Blood Glucose; Carbamates; Chemistry, Pharmaceutical; Delayed-Action Preparations; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Disease Models, Animal; Drug Compounding; Hypoglycemic Agents; Lactic Acid; Male; Nanoparticles; Particle Size; Piperidines; Polyethylene Glycols; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rats; Rats, Sprague-Dawley; Solubility | 2009 |
Studies on binary lipid matrix based solid lipid nanoparticles of repaglinide: in vitro and in vivo evaluation.
Topics: Administration, Oral; Animals; Biological Availability; Blood Glucose; Calorimetry, Differential Scanning; Carbamates; Chromatography, High Pressure Liquid; Diabetes Mellitus, Experimental; Drug Carriers; Drug Stability; Drug Storage; Hypoglycemic Agents; Lipids; Male; Microscopy, Electron, Transmission; Nanoparticles; Particle Size; Piperidines; Rats; Rats, Wistar; Solubility; Surface Properties; X-Ray Diffraction | 2011 |
In vivo and cytotoxicity evaluation of repaglinide-loaded binary solid lipid nanoparticles after oral administration to rats.
Topics: Animals; Biological Availability; Blood Glucose; Carbamates; Cell Survival; Cells, Cultured; Chromatography, High Pressure Liquid; Diabetes Mellitus, Experimental; Drug Carriers; Drug Stability; Hypoglycemic Agents; Lipids; Macrophages, Peritoneal; Male; Microscopy, Electron, Transmission; Nanoparticles; Particle Size; Phase Transition; Piperidines; Rats; Rats, Wistar; Solubility; Surface Properties | 2011 |
Lipid nanocarriers (GeluPearl) containing amphiphilic lipid Gelucire 50/13 as a novel stabilizer: fabrication, characterization and evaluation for oral drug delivery.
Topics: Administration, Oral; Animals; Blood Glucose; Calorimetry, Differential Scanning; Carbamates; Diabetes Mellitus, Experimental; Diglycerides; Drug Carriers; Drug Delivery Systems; Drug Stability; Fats; Feasibility Studies; Glucose Tolerance Test; Lipids; Nanoparticles; Nanotechnology; Oils; Particle Size; Piperidines; Rats; Surface-Active Agents | 2011 |
Influence of atorvastatin on the pharmacodynamic and pharmacokinetic activity of repaglinide in rats and rabbits.
Topics: Animals; Atorvastatin; Blood Glucose; Carbamates; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Diabetes Mellitus, Experimental; Drug Interactions; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoglycemic Agents; Piperidines; Pyrroles; Rabbits; Rats | 2012 |
Oxidative/nitrosative stress and protein damages in aqueous humor of hyperglycemic rabbits: effects of two oral antidiabetics, pioglitazone and repaglinide.
Topics: Animals; Antioxidants; Aqueous Humor; Carbamates; Diabetes Mellitus, Experimental; Glutathione Peroxidase; Hyperglycemia; Hypoglycemic Agents; Lipid Peroxidation; Male; Oxidative Stress; Pioglitazone; Piperidines; Rabbits; Thiazolidinediones | 2012 |
Studies on the glycemic and lipidemic effect of monopril and losartan in normal and diabetic rats.
Topics: Alloxan; Animals; Blood Glucose; Blood Proteins; Carbamates; Cholesterol, LDL; Diabetes Mellitus, Experimental; Disease Models, Animal; Drug Therapy, Combination; Egypt; Fosinopril; Gliclazide; Hyperlipidemias; Hypolipidemic Agents; Lipids; Losartan; Male; Piperidines; Rats; Rats, Sprague-Dawley; Triglycerides | 2004 |
Effects of repaglinide on oxidative stress in tissues of diabetic rabbits.
Topics: Administration, Oral; Animals; Blood Glucose; Body Weight; Carbamates; Diabetes Mellitus, Experimental; Glutathione Peroxidase; Glutathione Reductase; Hypoglycemic Agents; Kidney; Liver; Male; Oxidative Stress; Piperidines; Rabbits; Time Factors | 2005 |
Oxidative stress in kidney and liver of alloxan-induced diabetic rabbits: effect of repaglinide.
Topics: Animals; Blood Glucose; Body Weight; Carbamates; Catalase; Diabetes Mellitus, Experimental; Hypoglycemic Agents; Oxidative Stress; Piperidines; Rabbits; Superoxide Dismutase | 2005 |
Antioxidative and anti-inflammatory effects of repaglinide in plasma of diabetic animals.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Ascorbic Acid; Blood Glucose; Carbamates; Diabetes Mellitus, Experimental; Hypoglycemic Agents; Insulin; Piperidines; Rabbits | 2005 |
Modification of cardiac oxidative stress in alloxan-induced diabetic rabbits with repaglinide treatment.
Topics: Alloxan; Animals; Antioxidants; Blood Glucose; Carbamates; Diabetes Mellitus, Experimental; Insulin; Male; Myocardium; Oxidative Stress; Piperidines; Rabbits | 2005 |
Effect of antidiabetic agents on the increase in glycemia and insulinemia caused by refeeding in hereditarily diabetic rats.
Topics: Animals; Blood Glucose; Carbamates; Diabetes Mellitus, Experimental; Food; Glyburide; Hypoglycemic Agents; Insulin; Male; Piperidines; Rats; Starvation | 1997 |
Pancreatic islet responsiveness to D-glucose after repeated administration of repaglinide.
Topics: Administration, Oral; Animals; Blood Glucose; Carbamates; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Female; Glucose; Hypoglycemic Agents; Insulin; Islets of Langerhans; Piperidines; Rats; Rats, Wistar | 1998 |